Document is current

Article History

Received: 21 February 2023

Accepted: 12 May 2023

First Online: 27 July 2023

Declarations

:

: AJo is the clinical lead for the National Hip Fracture Database, at the Royal College of Physicians, London. Since completing the analyses RP is now funded by CeramTec UK Ltd. on an unrelated study. TC is the past British Orthopaedic Association (BOA) representative and previous board member of the Falls and Fragility Fracture Audit Project (which includes the National Hip Fracture Database), he helped set up and perform many of the BOA multidisciplinary peer reviews for hip fractures, he has design and educational contracts with Stryker, Acumed and Swemac. MKJ has received honoraria, unrestricted research grants, travel and/or subsistence expenses from: Amgen, Consilient Health, Kyowa Kirin Hakin, UCB, Abbvie, Sanofi and Besin healthcare. EMRM has received research funding from CeramTec UK limited. AJu has received consultancy fees from Freshfields, Bruckhaus, Derringer and Anthera Pharmaceuticals Ltd. JG has an educational contract with Stryker. Other authors declare that they have no competing interests.

: These were obtained from: NHS Health Research Authority, London City & East Research Ethics Committee (20/LO/0101); Royal College of Physicians Falls and Fragility Fracture Audit Programme (FFFAP/2018/003) and Healthcare Quality Improvement Partnership (HQIP330); NHS Wales Informatics Service (NWIS/30941); with an NHS Digital Data Sharing Agreement (DARS-NIC-334549-B1Y6X-v1.4).

: Not applicable.

: This publication is based on data collected by or on behalf of the Healthcare Quality Improvement Partnership, who have no responsibility or liability for the accuracy, currency, reliability and/or correctness of this publication.